Perioperative therapy for locoregional nonsmall-cell lung cancer

Journal of Surgical Oncology

Volumn 62, Issue 1, 1996, Pages 65-74

  Takita, Hiroshi ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

nonsmall cell lung cancer; perioperative therapy

Indexed keywords

ANTINEOPLASTIC AGENT; BCG VACCINE; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; LEVAMISOLE; MITOMYCIN; PICIBANIL; VINBLASTINE; VINDESINE;

CANCER ADJUVANT THERAPY; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; INTRAOPERATIVE PERIOD; INTRAPLEURAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; THORAX SURGERY; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; HUMANS; IMMUNOTHERAPY; LUNG NEOPLASMS; RADIOTHERAPY, ADJUVANT;

EID: 0029977997     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199605)62:1<65::AID-JSO14>3.0.CO;2-S     Document Type: Review

References (51)

1. Ginsberg RJ, Kris MG, Armstrong, JG: Cancer of the lung. In DeVita VT Jr, Hellman S, Rosenberg SA (eds): "Cancer: Principles and Practice of Oncology." Philadelphia: J.B. Lippincott, 1993, p 673-723.
2. Shields TW: Carcinoma of the lung. In Shields TW (ed): "General Thoracic Surgery." Philadelphia: Lea & Febiger, 1983, p 729-769.
3. Mountain CF: Value of the new TNM staging system for lung cancer. Chest 96:47S-49S, 1989.
4. Miller JD, Gorenstein LA, Patterson GA: Staging: The key to rational management of lung cancer. Ann Thorac Surg 53:170-178, 1992.
5. Bloedorn FG, Cowley RA, Cuccia CA, Mercado R Jr: Combined therapy: Irradiation and surgery in the treatment of bronchogenic carcinoma. Am J Roentgenol Rad Ther Nucl Med 85:875-885, 1961.
6. Warram J: Preoperative irradiation of cancer of the lung: Final report of a therapeutic trial. Cancer 36:914-925, 1975.
7. Shields TW, Higgins GA Jr, Lawton R, et al.: Preoperative x-ray therapy as an adjuvant in the treatment of bronchogenic carcinoma. J Thorac Cardiovasc Surg 59:49-61, 1970.
8. Pearson FG, DeLarue NC, Ilves R, et al.: Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung. J Thorac Cardiovasc Surg 83:1-11, 1982.
9. Van Houtte P, Rocmans P, Smets P, et al.: Postoperative radiation therapy in lung cancer: A controlled trial after resection of curative design. Int J Radiat Oncol Biol Phys 6:983-986, 1980.
10. The Lung Cancer Study Group: Effects of postoperative mediastinal radiation on completely resected Stage II and Stage III epidermoid cancer of the lung. N Engl J Med 315:1377-1381, 1986.
11. Matthews MJ, Kanhouwa S, Pickren J, Robinette D: Frequency of residual and metastatic tumor in patients undergoing curative surgical resection for lung cancer. Cancer Chemother Rep 4:63-67, 1973.
12. Feld R, Rubinstein LV, Weisenberger TH, Lung Cancer Study Group: Sites of recurrence in resected stage I non-small-cell lung cancer: A guide for future studies. J Clin Oncol 2:1352-1358, 1984.
13. Legha SS, Muggia FM, Carter SK: Adjuvant chemotherapy in lung cancer: Review and prospects. Cancer 39:1415-1424, 1977
14. Higby DJ, Wallace HJ Jr, Albert DJ, Holland JF: Diamminodichloroplatinum: A phase I study showing responses in testicular and other tumors. Cancer 33:1219-1225, 1974.
15. Holmes EC: Postoperative chemotherapy for non-small-cell lung cancer. Chest 103:30S-34S, 1993.
16. Morton DL, Barth A: Intralesional therapy. In DeVita VT Jr, Hellman S, Rosenberg SA (eds): "Biologic Therapy of Cancer." Philadelphia: J.B. Lippincott, 1995. p 691-704.
17. Lung Cancer Study Group (Lad T, Rubinstein L, Sadeghi A): The benefit of adjuvant treatment for resected locally advanced non-small-cell lung cancer. J Clin Oncol 6:9-17, 1988.
18. Feld R, Rubinstein L, Thomas PA, Lung Cancer Study Group: Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small cell lung cancer. J Natl Cancer Inst 85:299-306, 1993.
19. Ohta M, Tsuchiya R, Shimoyama M, et al.: Adjuvant chemotherapy for completely resected stage III nonsmall-cell lung cancer: Results of a randomized prospective study. J Thorac Cardiovasc Surg 106:703-708, 1993.
20. Takita H., Hollinshead AC, Rizzo DJ, et al.: Treatment of inoperable lung carcinoma: A combined modality approach. Ann Thorac Surg 28:363-368, 1979.
21. Takita H, Regal A-M, Antkowiak JG, et al.: Chemotherapy followed by lung resection in inoperable non-small cell lung carcinomas due to locally far-advanced disease. Cancer 57:630-635, 1986.
22. 0 non-small cell lung cancer. Cancer Treat Rep 71:895-900, 1987.
23. Sridhar KS, Thurer R, Kim Y, et al.: Multimodality treatment of non-small cell lung cancer: Response to cisplatin, VP-16, and 5-FU chemotherapy and to surgery and radiation therapy. J Surg Oncol 38:193-215, 1988.
24. 0 non-small cell lung cancer: Long-term follow-up in 41 patients. J Surg Oncol 40:266-274, 1989.
25. Faber LP, Kittle CF, Warren WH, et al.: Preoperative chemotherapy and irradiation for stage III non-small cell lung cancer. Ann Thorac Surg 47:669-677, 1989.
26. Weiden P, Piantadosi S: Preoperative chemoradiotherapy in stage III non-small cell lung cancer (NSCLC): A phase II study of the Lung Cancer Study Group (LCSG). Proc. ASCO 7:197, 1988.
27. Strauss GM, Herndon JE, Sherman DD, et al.: Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: Report of a Cancer and Leukemia Group B phase II study. J Clin Oncol 10:1237-1244, 1992.
28. Kirn DH, Lynch TJ, Mentzer SJ, et al.: Multimodality therapy of patients with stage IIIA, N2 non-small-cell lung cancer: Impact of preoperative chemotherapy on resectability and downstaging. J Thorac Cardiovasc Surg 106:696-702, 1993.
29. Martini N, Kris MG, Flehinger BJ, et al.: Preoperative chemotherapy for stage IIIa (N2) lung cancer: The Sloan-Kettering experience with 136 patients. Ann Thorac Surg 55:1365-1374, 1993.
30. Rusch VW, Albain KS, Crowley JJ, et al.: Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy: A Southwest Oncology Group trial. J Thorac Cardiovasc Surg 105:97-106, 1993.
31. Ruckdeschel JC, Holmes EC: Preoperative chemotherapy for locally advanced non-small-cell lung cancer. Chest Surg Clin North Am 1:1-12, 1991.
32. Roth JA, Fossella F, Komaki R, et al.: A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer J Natl Cancer Inst 86:673-680, 1994.
33. Dillman RO, Seagren SL, Propert KJ, et al.: A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 323: 940-945, 1990.
34. Le Chevalier T, Arriagada R, Quoix E, et al.: Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: First analysis of a randomized trial in 353 patients. J Natl Cancer Inst 83:417-423, 1991.
35. Fouillart P, Mathe G, Palangie T, et al.. Trial of BCG immunotherapy in the treatment of resectable squamous cell carcinoma of the bronchus (stages I and II). Recent Results Cancer Res 62:151-155, 1977.
36. Jansen HM, The TH, de Gast GC, et al.: Adjuvant immunotherapy with BCG in squamous-cell bronchial carcinoma. Immune-reactivity in relation to immunostimulation (preliminary results in a controlled trial). Thorax 33:429-438, 1978.
37. Mineo TC, Rea S, Ricci C: Immunoterapia con BCG del carcinoma polmorare squamoso resecato Al I E II stadio. Proc. 16th Natl Cong Thoracic Surgery, Taormina, Italy, May 1978.
38. Miyazawa N, Suemasu K, Ogata T, et al.: BCG immunotherapy as an adjuvant to surgery in lung cancer: A randomized prospective clinical trial. Jap J Clin Oncol 9:19-26, 1979.
39. Millar JW, Roscoe P, Pearce SJ, et al.: Five-year results of a controlled study of BCG immunotherapy after surgical resection in bronchogenic carcinoma. Thorax 37:57-60, 1982.
40. Perlin E, Oldham RK, Weese JL, et al.: Carcinoma of the lung: Immunotherapy with intradermal BCG and allogeneic tumor cells. Im J Radiat Oncol Biol Phys 6:1033-1039, 1980.
41. Takita H: Effect of postoperative empyema on survival of patients with bronchogenic carcinoma. J Thorac Cardiovasc Surg 59:642-644, 1970.
42. McKneally MF, Maver C, Lininger L, et al.: Four-year follow-up on the Albany experience with intrapleural BCG in lung cancer. J Thorac Cardiovasc Surg 81:485-492, 1981.
43. Mountain CF, Gail MH: Surgical adjuvant intrapleural BCG treatment for stage I non-small cell lung cancer: Preliminary report of the National Cancer Institute Lung Cancer Study Group. J Thorac Cardiovasc Surg 82:649-657, 1981.
44. Woodruff M, Walbaum P: A phase-II trial of corynebacterium parvum as adjuvant to surgery in the treatment of operable lung cancer. Cancer Immunol Immunother 16:114-116, 1983.
45. Ludwig Lung Cancer Study Group (Kaufmann M): Adverse effect of intrapleural corynebacterium parvum as adjuvant therapy in resected stage I and II non-small cell carcinoma of the lung. J Thorac Cardiovasc Surg 89:842-847, 1985.
46. Watanabe Y, Iwa T: Clinical value of immunotherapy for lung cancer by the streptococcal preparation OK-432. Cancer 53:248-253, 1984.
47. Amery WK, Cosemans J, Gooszen HC, et al.: Adjuvant immunotherapy with levamisole in resectable lung cancer: A double-blind clinical evaluation. Cancer Immunol Immunother 7:191-198. 1979.
48. Van Houtte P, Bondue H, Rocmans P, et al.: Adjuvant immunotherapy by levamisole in resectable lung cancer: A control study. Europ J Cancer 16:1597-1601, 1980.
49. Hollinshead AC, Stewart THM, Herberman RB: Delayed-hypersensitivity reactions to soluble membrane antigens of human malig-nant lung cells. J Natl Cancer Inst 52:327-338, 1974.
50. Stewart THM, Hollinshead AC, Harris JE, et al.: Immunochemotherapy of lung cancer. Ann NY Acad Sci 277:436-466, 1976.
51. Takita H, Hollinshead AC, Adler RH, et al.: Adjuvant, specific, active immunotherapy for resectable squamous cell lung carcinoma. A 5-year survival analysis. J Surg Oncol 46:9-14, 1991.